Abstract
The healthcare sector confronts challenges from overloaded tumor board meetings, reduced discussion durations, and care quality concerns, necessitating innovative solutions. Integrating Clinical Decision Support Systems (CDSSs) has a potential in supporting clinicians to reduce the cancer burden, but CDSSs remain poorly used in clinical practice. The emergence of OpenAI's ChatGPT in 2022 has prompted the evaluation of Large Language Models (LLMs) as potential CDSSs for diagnosis and therapeutic management. We conducted a scoping review to evaluate the utility of LLMs like ChatGPT as CDSSs in several medical specialties, particularly in oncology, and compared users' perception of LLMs with the actually measured performance of these systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
